Intest Res.  2025 Jan;23(1):85-95. 10.5217/ir.2024.00066.

The impact of the COVID-19 pandemic on clinical practices related to colorectal cancer and colonoscopy in South Korea: a nationwide population-based study

• Yoon JY
• Lee MH
• Kwak MS
• Cha JM

• KMID: 2564399
• DOI: http://doi.org/10.5217/ir.2024.00066

Abstract

Background/Aims
Despite of the coronavirus disease 2019 (COVID-19) pandemic, there is little data regarding its impact on colorectal cancer (CRC)-related clinical practice. This study aimed to assess the changes in its impact during the COVID-19 pandemic.
Methods
This was a retrospective national population-based study using the Health Insurance Review and Assessment database from January 2019 to December 2021. The number of patients in 2020 and 2021 was compared with those in 2019 for the diagnostic and therapeutic colonoscopy, CRC-related operation, and any treatment for CRC.
Results
The annual number of patients undergoing diagnostic colonoscopies decreased by 6.9% in 2020 but increased 8.1% in 2021, compared to those in 2019; number of patients undergoing therapeutic colonoscopies increased by 6.0% and 37.7% in 2020 and 2021, respectively; number of patients operated for CRC decreased by 4.2% in 2020 and increased by 2.3% in 2021. The number of patients treated for CRC decreased by 2.8% in 2020 and increased by 4.4% in 2021. Diagnostic and therapeutic colonoscopies and any CRC-related treatment decreased by 43.8%, 37.5%, and 11.3% in March 2020, during the first surge of COVID-19, but increased by 26.0%, 58.1%, and 9.5% in June 2021, respectively. CRC-related operations decreased by 24.1% in April 2020 and increased by 12.6% in August 2021.
Conclusions
Negative impact of the COVID-19 pandemic on clinical practices related to CRC completely recovered within second year. It could be considered for the development of an optimal strategy on CRC management in response to the pandemic-driven crisis.

Keyword

Colonoscopy; Colorectal neoplasms; COVID-19; Surgical procedures; Mass screening

Figure

• 

  Fig. 1. A year-wise comparison of monthly number of patients who underwent diagnostic colonoscopies in South Korea.

• 

  Fig. 2. A year-wise comparison of the monthly number of patients who underwent therapeutic colonoscopies in South Korea.

• 

  Fig. 3. A year-wise comparison of the monthly number of patients who underwent surgery for colorectal cancers in South Korea.

• 

  Fig. 4. A year-wise comparison of the monthly number of patients who claimed to have colorectal cancer in South Korea.

Reference

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497–506.

2. Kim JY, Choe PG, Oh Y, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020; 35:e61.

3. Sultan S, Lim JK, Altayar O, et al. AGA rapid recommendations for gastrointestinal procedures during the COVID-19 pandemic. Gastroenterology. 2020; 159:739–758.

4. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382:929–936.

5. Rees CJ, East JE, Oppong K, et al. Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: guidance from the British Society of Gastroenterology. Clin Med (Lond). 2020; 20:352–358.

6. Issaka RB, Taylor P, Baxi A, Inadomi JM, Ramsey SD, Roth J. Model-based estimation of colorectal cancer screening and outcomes during the COVID-19 pandemic. JAMA Netw Open. 2021; 4:e216454.

7. Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review. J Gastrointest Cancer. 2022; 53:730–744.

8. Kopel J, Ristic B, Brower GL, Goyal H. Global impact of COVID-19 on colorectal cancer screening: current insights and future directions. Medicina (Kaunas). 2022; 58:100.

9. Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017; 32:718–728.

10. Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health. 2014; 36:e2014008.

11. Kim HK, Song SO, Noh J, Jeong IK, Lee BW. Data configuration and publication trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database. Diabetes Metab J. 2020; 44:671–678.

12. Health Insurance Review and Assessment. Standard guide to calculating disease behavior statistics [Internet]. c2023. [cited 2024 May 10]. http://opendata.hira.or.kr/co.apndFile.dir/download.do?fileNm=illnessBehavior.pdf.

13. Kim KH, Kim SB, Kim TN. Changes in endoscopic patterns before and during COVID-19 outbreak: experience at a single tertiary center in Korean. World J Clin Cases. 2021; 9:3576–3585.

14. Mahadev S, Aroniadis OS, Barraza L, et al. Impact of the COVID-19 pandemic on endoscopy practice: results of a crosssectional survey from the New York metropolitan area. Gastrointest Endosc. 2020; 92:788–789.

15. Meyer A, Drouin J, Zureik M, Weill A, Dray-Spira R. Colonoscopy in France during the COVID-19 pandemic. Int J Colorectal Dis. 2021; 36:1073–1075.

16. Morris EJ, Goldacre R, Spata E, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021; 6:199–208.

17. Lui TK, Leung K, Guo CG, Tsui VW, Wu JT, Leung WK. Impacts of the coronavirus 2019 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: a population-based study. Gastroenterology. 2020; 159:1164–1166.

18. Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21:1023–1034.

19. Whaley CM, Pera MF, Cantor J, et al. Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw Open. 2020; 3:e2024984.

20. London JW, Fazio-Eynullayeva E, Palchuk MB, Sankey P, McNair C. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Inform. 2020; 4:657–665.

21. Peña-Rey I, Almazán R, Rodríguez-Camacho E, Cubiella J. Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results. Rev Esp Enferm Dig. 2021; 113:119–121.

22. Repici A, Aragona G, Cengia G, et al. Low risk of COVID-19 transmission in GI endoscopy. Gut. 2020; 69:1925–1927.

23. Choi E, Jeon J, Kim J. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests. Eur J Cancer Care (Engl). 2019; 28:e13008.

24. Ek S. Gender differences in health information behaviour: a finnish population-based survey. Health Promot Int. 2015; 30:736–745.

25. Galasso V, Pons V, Profeta P, Becher M, Brouard S, Foucault M. Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries. Proc Natl Acad Sci U S A. 2020; 117:27285–27291.

26. Tan J, Yoshida Y, Ma KS, Mauvais-Jarvis F, Lee CC. Gender differences in health protective behaviours and its implications for COVID-19 pandemic in Taiwan: a population-based study. BMC Public Health. 2022; 22:1900.

27. Soneji S, Beltrán-Sánchez H, Yang J, Mann C. Population-level death rates from novel coronavirus (COVID-19) in South Korea. Asia Pac J Public Health. 2021; 33:293–295.

28. Tan KK, Lau J. Cessation of cancer screening: an unseen cost of the COVID-19 pandemic? Eur J Surg Oncol. 2020; 46:2154–2155.

29. Zorzi M, Hassan C, Capodaglio G, et al. Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer. Endoscopy. 2020; 52:871–876.

30. Ricciardiello L, Ferrari C, Cameletti M, et al. Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality. Clin Gastroenterol Hepatol. 2021; 19:1410–1417.

31. Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020; 21:1035–1044.

32. Yong JH, Mainprize JG, Yaffe MJ, et al. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. J Med Screen. 2021; 28:100–107.

33. Kregting LM, Kaljouw S, de Jonge L, et al. Effects of cancer screening restart strategies after COVID-19 disruption. Br J Cancer. 2021; 124:1516–1523.

34. Gupta S, Lieberman D. Screening and surveillance colonoscopy and COVID-19: avoiding more casualties. Gastroenterology. 2020; 159:1205–1208.

35. Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020; 17:773–780.

36. Kadakuntla A, Wang T, Medgyesy K, et al. Colorectal cancer screening in the COVID-19 era. World J Gastrointest Oncol. 2021; 13:238–251.

37. Gupta S, Coronado GD, Argenbright K, et al. Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit. CA Cancer J Clin. 2020; 70:283–298.

38. Budd J, Miller BS, Manning EM, et al. Digital technologies in the public-health response to COVID-19. Nat Med. 2020; 26:1183–1192.

39. El Bizri M, El Sheikh M, Lee GE, Sewitch MJ. Mobile health technologies supporting colonoscopy preparation: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2021; 16:e0248679.